C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 403/12 (2006.01) A61K 31/437 (2006.01) A61K 31/4375 (2006.01) A61K 31/4995 (2006.01) C07D 401/12 (2006.01) C07D 401/14 (2006.01) C07D 403/04 (2006.01) C07D 405/14 (2006.01) C07D 413/14 (2006.01) C07D 471/04 (2006.01) C07D 519/00 (2006.01)
Patent
CA 2348734
Compounds of the invention are useful in inhibiting thrombin and associated thrombotic occlusions having the structure (I) or a pharmaceutically acceptable salt thereof, wherein b is NY1 or O; c is CY2 or N; d is CY3 or N; e is CY4 or N; f is CY5 or N; g is CY6 or N; Y4, Y5, and Y6 are independently hydrogen, C1-4 alkyl, or halogen; Y1 and Y2 are independently hydrogen, C1-4 alkyl, C3-7 cycloalkyl, halogen, NH2, OH or C1-4 alkoxy, and Y3 is hydrogen, C1-4 alkyl, C3-7 cycloalkyl, halogen, -CN, NH2, OH or C1-4 alkoxy; A is (II), (III), (IV), (V) or (VI); and W, W1, R1, R3, R4, R5, X and Z are defined in the specification.
L'invention concerne des composés pouvant inhiber la thrombine et les occlusions thrombotiques associées, et présentant la structure de la formule (I), où b désigne NY?1¿ ou O ; c désigne CY?2¿ ou N ; d désigne CY?3¿ ou N ; e désigne CY?4¿ ou N ; f désigne CY?5¿ ou N ; g désigne CY?6¿ ou N ; Y?4¿, Y?5¿ et Y?6¿ désignent indépendamment l'hydrogène, un alkyle C¿1-4?, ou un halogène ; Y?1¿ et Y?2¿ désignent indépendamment l'hydrogène, un alkyle C¿1-4?, un cycloalkyle C¿3-7?, un halogène, NH¿2?, OH ou alcoxy C¿1-4?, et Y?3¿ désigne l'hydrogène, un alkyle C¿1-4?, un cycloalkyle C¿3-7?, un halogène, -CN, NH¿2?, OH ou alcoxy C¿1-4?; ou un sel pharmaceutiquement acceptable desdits composés. A désigne l'un des composés de formule (II), (III), (IV), (V) ou (VI) ; et W, W?1¿, R?2¿, R?3¿, R?4¿, R?5¿, X et Z sont tels que définis dans le descriptif.
Barrow James C.
Burgey Christopher
Coburn Craig
Dorsey Bruce D.
Isaacs Richard
Merck & Co. Inc.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Thrombin inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thrombin inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thrombin inhibitors will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1490587